Eudaemon Awarded $4m MDF Funding To Develop And Commercialise Next Generation Condom

Eudaemon Technologies has received $4m in funding from the NSW Medical Devices Fund (MDF) to continue the development and commercialisation of its next generation hydrogel condom.

Eudaemon was a previous recipient of the prestigious NSW Medical Device Fund in 2019 and this further injection of funding will support Eudaemon in the clinical trial development and commercialisation of their next generation condom project to address sexual and reproductive health and wellness needs in NSW, Australia, and the world.

Read more: